Kanagawa, Japan

Yuuko Nakatani

This inventor holds 1 USPTO granted patent. Top assignee: Meiji Seika Kabushiki Kaisha. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yuuko Nakatani. Retrieved from https://idiyas.com/inventor/yuuko-nakatani-yoyd2jst

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yuuko Nakatani: Innovator in Antipsychotic Research

Introduction

Yuuko Nakatani is a prominent inventor based in Kanagawa, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of antipsychotic medications. Her innovative work has led to the creation of valuable compounds that can aid in mental health treatment.

Latest Patents

Yuuko Nakatani holds a patent for "Antipsychotic benzoisothiazolyl piperazine derivatives." This patent represents her commitment to advancing medical science and improving therapeutic options for patients suffering from mental health disorders. She has successfully secured 1 patent in her field.

Career Highlights

Throughout her career, Nakatani has been associated with Meiji Seika Kabushiki Kaisha, a leading company in the pharmaceutical industry. Her work at this organization has allowed her to collaborate with other talented professionals and contribute to groundbreaking research.

Collaborations

Yuuko Nakatani has worked alongside esteemed colleagues such as Yoshimasa Fukuda and Toshiro Sasaki. These collaborations have fostered an environment of innovation and creativity, leading to advancements in their shared field of expertise.

Conclusion

Yuuko Nakatani's contributions to antipsychotic research exemplify her dedication to improving mental health treatments. Her innovative spirit and collaborative efforts continue to inspire advancements in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…